TRIPath Lab, in collaboration with the UWBC Gene Expression Center (GEC) is excited to offer Visium Spatial Gene Expression (10X Genomics), a technology that allows researchers to simultaneously visualize cells and their location in a tissue sample and measure …
Resource Spotlight
Cancer Metabolomics Update
Cancer Metabolomics – or CaMetab – is a developing core which operates within the Laboratory for Biomolecular Mass Spectrometry (LBMS). LBMS is a collaborative campus resource founded in 2016 with joint support from the University …
Hi-plex molecular profiling arrives to TRIPath: The nCounter MAX system from NanoString
The TRIPath Lab is excited to introduce the nCounter MAX system on January 2021. The nCounter platform provides a simple and cost-effective solution for multiplex molecular profiling of up to 800 RNA, DNA, or protein …
Digital Spatial profiling coming to the TRIPath Lab on 2021!
The GeoMx Digital Spatial Profiler (DSP) from NanoString is a benchtop instrument that combines spatial and molecular profiling information and high-plex immunohistochemistry (IHC) or In situ hybridization (ISH) of FFPE or frozen tissue slides. This system is …
New Equipment Announcement – Ultra High-Resolution SPECT/CT
The Small Animal Imaging & Radiotherapy Facility (SAIRF) was successfully awarded an NIH Shared Instrumentation Grant (SIG) S10 for an MILabs U-SPECT/CTUHR (ultra high-resolution) system. This system, which is tentatively planned to be installed late summer of …
Resource Spotlight: Experimental Pathology Laboratory
Learn about the Experimental Pathology Laboratory, which provides histological services at low cost to UWCCC members. Without the EPL, labs would have to dedicate at least 1 FTE to histology and buy the specialized equipment needed to process, cut, and stain tissue.
Resource Spotlight: Clinical Research QA and Compliance
The scope of the Protocol Review and Monitoring Committee is to scientifically evaluate and prioritize cancer-related studies derived and supported from institutional sources, including those originating from other cancer centers, or from industry.